carfilzomib,dexamethasone,isatuximab
sanofi,amgen
isatuximab plus carfilzomib/dexamethasone maintains survival benefit in relapsed multiple myeloma #ims2022 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.